FROM EMERGING AGENTS TO BIOMARKERS Integrating Scientific Advances into MS Management

Credit Area For Credit: Register/Login     View Activity As Guest

Release Date: Jul 30, 2013          Expiration Date: Jul 30, 2014



By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.



Program Description


MS is a chronic, progressive, inflammatory, and neurodegenerative disease of the central nervous system that leads to significant disability. The push towards ever earlier diagnosis and treatment of MS and the rapid emergence of novel agents are causing considerable changes to the management of the disease. The decisions regarding when to initiate treatment and which agents to use, along with deliberations on long-term management, are all increasingly difficult, with adherence issues continuing to negatively impact outcomes and add to the intricacy of MS treatment. The emerging data on biomarker research, aimed at increasing diagnostic accuracy and aiding in management, adds to the complexity of decision-making in MS.

This program provides neurologists and MS specialists with updates on the latest advances in MS diagnosis and management, so that they can optimize outcomes for their patients with MS.


Faculty


SUHAYL DHIB-JALBUT, MD
Professor and Chairman
Department of Neurology
Rutgers-Robert Wood Johnson Medical School
Chief, Neurology Service
Robert Wood Johnson University Hospital
New Brunswick, NJ
Read Biography

CLYDE E. MARKOWITZ, MD
Chief, MS Section
Director, MS Center
Associate Professor of Neurology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA
Read Biography

AARON E. MILLER, MD
Professor of Neurology
Medical Director, The Corinne Goldsmith Dickinson
Center for Multiple Sclerosis
Mount Sinai Medical Center
New York, NY
Read Biography


Target Audience


This activity is intended for neurologists, MS nurses, and other health care providers actively involved in the care of patients with multiple sclerosis.


Educational Objectives


At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Describe the mechanisms of action and efficacy and safety profiles of current and emerging DMD therapies in MS
  • Select and initiate effective DMD therapies earlier in the course of MS
  • Provide patient-tailored therapy to optimize adherence, increase effectiveness, and improve patient outcomes
  • Apply improved MRI measures and diagnostic biomarkers to allow for earlier diagnosis of MS
  • Assess the clinical utility of MRI measures and biomarkers to monitor disease activity and response to DMD therapy

Accreditation


Physicians – This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Nurses – Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Designation Statement


Physicians – The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding this activity, please email contact@potomacme.org

Nurses – This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Please contact Global at inquire@globaleducationgroup.com or 303-395-1782.


Disclosure Statement


Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty/steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Suhayl Dhib-Jalbut, MD: Consultant: Bayer, Biogen Idec, EMD Serono, Teva; Speaker: Teva; Primary Investigator: Teva

Clyde E. Markowitz, MD: Consultant: Acorda, Bayer, Biogen Idec, Genentech, Novartis, Questor, Sanofi-Genzyme, Teva

Aaron E. Miller, MD: Research: Acorda, Biogen Idec, Genentech, Genzyme, Novartis, Roche, Sanofi-Aventis; Consultant: Acorda, Biogen Idec, EMD Serono (Merck Serono), GlaxoSmithKline, Neuron Biotech, Novartis, Ono Pharmaceutical, Sanofi-Aventis, Teva

Non-faculty Content Contributors:
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Matthew Horn, MD; Blair St. Amand; Jay Katz; Laurie Muldowney, MD; Ashley Marostica, MSN, RN; Amanda Glazar, PhD: Nothing to Disclose


FDA Disclosure


The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


System Requirements


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.

Instructions for Participants and Obtaining CME Credit


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 1.0 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test.


Jointly Sponsored By


Potomac Center for Medical Education and Rockpointe

Co-provided by


Global Education Group

Supported By


Supported by an independent medical educational grant from TEVA


By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.